Ultrafast Shape Recognition for Similarity Search in Molecular Databases
Pedro J. Ballester1 & W. Graham Richards1
1Physical & Theoretical Chemistry Laboratory,
SUMMARY:
Molecular
databases are routinely screened for compounds that most closely resemble a
molecule of known biological activity to provide novel drug leads. It is widely
believed that 3D molecular shape is the most discriminating pattern for
biological activity, as it is directly related to the steep repulsive part of
the interaction potential between the drug-like molecule and its macromolecular
target. However, efficient comparison of molecular shape is currently a
challenge. Here we show that a new approach [1][2]
based on moments of distance distributions is able to recognise molecular shape
at least three orders of magnitude faster than current methodologies. Such an ultrafast
method permits the identification of similarly shaped compounds within the
largest molecular databases. In addition, the problematic requirement of
aligning molecules for comparison is circumvented, as the proposed
distributions are independent of molecular orientation.
KEYWORDS:
Molecular Shape; Similarity Search;
Pattern Recognition; Data Explosion; Virtual Screening.
REFERENCES:
[1] Ballester,
P.J. and Richards, W.G.: "Ultrafast Shape
Recognition to Search
Compound
Databases for Similar Molecular Shapes", Journal of Computational
Chemistry (In Press)
[2] Ballester,
P.J. and Richards, W.G.: "Ultrafast Shape
Recognition for Similarity Search in Molecular Databases", Proceedings of
the Royal Society A (In Press)
Class A b-lactamases: a QM/MM study of their mechanism of resistance
to antibiotics.
Juliette J. Pradon, Dr. Jeremy N. Harvey and Dr. Adrian J. Mulholland.
b-lactam compounds work by irreversibly inhibiting penicillin-binding proteins, which are enzymes responsible for the synthesis and repair of peptidoglycan, a major structural component of bacterial cell walls. The production of b-lactamase enzymes by many pathogenic bacteria makes them resistant to both naturally occurring and synthetically developed b-lactam compounds, such as penicillins, cephalosporins and carbapenems. These enzymes are able to hydrolyse the amide bond in the b-lactam ring. This represents a growing problem in current primary care medicine.
For class A b-lactamases, which are the most prevalent form in pathological strains, the overall catalytic mechanism is a two-step process: the enzyme is rapidly acylated at residue Ser70 by the b-lactam; the serine ester intermediate is then hydrolysed, leading to release of the cleaved, inactive antibiotic. Whilst the process of deacylation is widely accepted, there is no such consensus on the acylation step.
The acylation mechanism of a class A TEM-1
b-lactamase by
the anionic form of benzylpenicillin was studied with
the combined Quantum Mechanics/Molecular Mechanics (QM/MM) methodology.
Modelling reactions
of drugs in human cytochrome P450 enzymes
Richard Lonsdale, Dr. Jeremy Harvey and Dr. Adrian Mulholland
Cytochrome P450 (CYP) is an important metalloenzyme found in plants, animals and bacteria. It activates molecular oxygen and catalyzes stereoselective and regioselective oxygen insertion reactions with a wide variety of organic compounds. These enzymes are of particular interest in the field of drug metabolism, because they play an important role in the disposition of drugs and in their pharmacological and toxicological effects. A key aim is the prediction of selectivity of reactions of drugs with different P450 isozymes. Combined quantum mechanics/molecular mechanics methods now allow reactions in P450 enzymes to be modelled, and provide a promising approach to analysing determinants of selectivity in drug metabolism.
CYP 2C9 is one of the major drug metabolizing isoforms
of the enzyme. It contributes to the metabolism of around 16% of drugs that are
in current clinical use. The large and highly flexible substrate binding cavity
enables it to bind multiple substrate molecules. This may give rise to adverse
drug reactions. The widely used anticoagulant drug S-warfarin undergoes stereoselective
hydroxylation by CYP 2C9 to the biologically inactive S-7-hydroxywarfarin. A crystal structure exists of CYP 2C9 complexed with S-warfarin which places the warfarin
molecule 10 Å from the active oxidizing species. We have investigated the
mobility and conformational behaviour of warfarin in
CYP by molecular dynamics simulations. This has provided a basis for modelling
the oxygen insertion reaction of S-warfarin in CYP 2C9. The results provide detailed insight
into the reaction in the enzyme active site.
In the case of allylic substrates, regioselectivity is an important consideration. For example, the oxidation of cyclohexene by the bacterial P450cam from pseudomonas putida results in both C=C bond epoxidation and allylic hydroxylation products in approximately equal amounts. In contrast, oxidation of propene gives exclusively epoxidation-type products. Application of QM/MM methodology to this problem yields relative barriers for bond-activation in these processes which are consistent with experimental findings.
References
C. M. Bathelt, L. Ridder, A. J. Mulholland and J. N. Harvey, Org. Biomol. Chem., 2004, 2, 2998-3005
C. M. Bathelt, J. Zurek, A. J. Mulholland and J. N. Harvey, J. Am. Chem. Soc., 2005, 127, 12900-12908.
A. J. Mulholland, Drug Discovery Today, 2005, 10, 1393-1402
Modelling
the mechanism of citrate synthase: evidence for arginine acting as acid
Marc van der Kamp, Adrian Mulholland
Centre for Computational Chemistry, School of Chemistry, University of Bristol, UK.
Marc.vanderKamp@bristol.ac.uk
Citrate synthase
catalyses the first step in the citric acid cycle: the conversion of oxaloacetate to citrate. The first reaction in this
conversion is the Claisen condensation of acetyl-CoA with the carbonyl of oxaloacetate.
This reaction comprises two steps: proton abstraction from acetyl-CoA to form an enolate (enolization, previously thought to be rate limiting1)
and the subsequent nucleophilic attack of the enolate on the carbonyl carbon of oxaloacetate
(condensation). The overall mechanism of this important enzyme remains
uncertain.
We have identified a new
mechanism for the reaction, in calculations which have also highlighted
important shortcomings in standard modelling methods. Potential energy profiles
both reaction steps were obtained using QM/MM modelling at several QM levels,
including high-level ab initio
approaches. Higher level results (e.g.
Analysis of stabilization by
the enzyme and key individual residues along the full profile was performed.
This indicates that the enzyme primarily stabilizes between the transition
states of the condensation reaction, providing more evidence that this second
step is likely to be rate limiting.
1. Lenz, H. et al., Eur. J. Biochem. (1971), 24,
207-15
Understanding the Extracellular Matrix of Microbial Biofilms:
Molecular Modelling the Structure and Dynamics of Alginate in the Condensed
Phase
Alginate copolymers are a key component of the extracellular polymeric substances (EPS) matrix of microorganisms such as P.
aeruginosa. Alginate helical chains comprise
alternating blocks of a-(1®4)-linked L-guluronate and b-(1®4)-linked D-mannuronate. To understand the microscopic behaviour and interactions
of these flexible acidic sugars within the EPS matrix, a suitable molecular-level
model is required. To this end, we derive a molecular mechanical force field for
the two uronic acids, with validation against available
experimental data. We subsequently explore alginate models of increasing
complexity, from disaccharides to single- and double-stranded oligomer helices, employing the techniques of molecular
dynamics and replica-exchange molecular dynamics. The condensed phase behaviour
of these systems is discussed, including the role of counterions
and the implications for interaction with other constituents of the EPS matrix.
Robert J Deeth
Inorganic Computational Chemistry Group,
Abstract:
Transition metal (TM) centres play crucial roles in many metalloproteins and are finding increasing applications in pharmaceuticals. However, despite their growing significance in biology and medicine, computational approaches to TM systems remain underdeveloped. Their structural and electronic complexity apparently precludes a general molecular mechanics (MM) approach while quantum mechanics (QM) is expensive. Consequently, simulations of TM-containing molecules tend to be restricted to small systems which are tractable for QM or tend to require more-or-less crude assumptions to facilitate classical modelling.
The central feature
which distinguishes TMs from the lighter ‘organic’
elements is the crucial role played by the d electrons. The d electrons are structurally end
electronically non-innocent and their influence must be explicitly or
implicitly incorporated in any theoretical treatment. One way of including d electron effects is
via ligand field theory (LFT) which is empirical, and
thus computationally efficient, but accurate and flexible enough to enable TM
atoms to be placed on the same footing as any other atom type in the MM force
field. Consequently, by augmenting
conventional MM with an explicit calculation of d electron effects via LFT, we
arrive at ligand field molecular mechanics (LFMM)
which is capable of delivering the accuracy of full QM but several orders of
magnitude faster. The LFMM offers the
potential for the accurate modelling of electronically challenging metals
centres like Cu(II), provides a common energy
reference for treating multiple spin states in Ni(II) and Fe(II) systems and is
efficient enough to be applied to entire protein systems.
Molecular dynamics study of chemically
engineered green
fluorescent protein mutants: comparison of intramolecular fluorescence resonance energy transfer
efficiency
Felicity L. Mitchell1,
Filipp Frank2, Gabriel E. Marks1,
Kenneth T. Douglas1, Miho
Suzuki3, Richard A. Bryce1*
1School of
Pharmacy and Pharmaceutical Sciences,
Due
to its unusual spectroscopic properties, green fluorescent protein has become a
useful tool in molecular genetics, biochemistry and cell biology. Here, we
computationally explore the behaviour of two green fluorescent protein
constructs, designed as bioprobes for enzymatic
triggering using intramolecular fluorescence resonance
energy transfer (FRET). These constructs differ in the location of the intramolecular FRET partner, an attached chemical chromophore (either at a
N-terminal or C-terminal site). We apply the temperature replica exchange
molecular dynamics method to the two flexible constructs in conjunction with a
generalised Born implicit solvent model, permitting
efficient sampling of protein/chromophore phase
space. The calculated efficiency of FRET was derived from the inter-chromophore distance and orientation factor k2. In agreement with experiment,
the construct with the C-terminally attached dye was found to have
significantly higher energy transfer efficiency than observed for the
N-terminal construct. The molecular basis for this observation is discussed.
The influence
of MD simulations on ligand-protein docking
Emi Psachoulia, Philip C. Biggin
Dept. of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, U.K.
Docking techniques are widely used to find plausible conformations of a ligand and its receptor. Current docking programs typically allow flexible ligands and limited protein flexibility typically just sidechain rotamers. Molecular dynamics (MD) has been suggested as a useful complementary tool for use in conjunction with molecular docking programs [1]. However, the influence of MD on docking has not yet been systematically examined.
The aim of this project was to examine
the influence of molecular dynamics on the docking using a subset of CCDC/Astex test set previously used to validate
11 protein-ligand complexes from different classes of protein, i.e. hydrolase, kinase, lyase, etc., were chosen and 10 ns MD protein only simulations were run with Gromacs. Protein stability was accessed by Cα-RMSD calculations of the whole protein and of the residues at the binding pocket. Snapshots were taken from a 5 ns portion of the trajectory, where the proteins were stable, and ligands were docked back to these frames.
The results and relevance to future drug-design approaches will be discussed.
1. Alonso H, Bliznyuk AA, Gready JE. Combining docking and molecular
dynamic simulations in drug design. Med. Res. Rev. 2006; 26: 531-568.
2. Nissink JW, Murray C, Hartshorn M, Verdonk ML, Cole JC, Taylor R. A new test set for validating predictions of protein-ligand interaction. Proteins. 2002; 49: 457-471.